Patient Information

Rises in LDL and HDL cholesterol, triglycerides tied to lower diabetes risk


 

Higher levels of LDL cholesterol, HDL cholesterol, and triglycerides over a lifetime are protective against type 2 diabetes, a Mendelian randomization study has shown. Jon White, PhD, of University College London and his co-investigators sought to shed light on the role of the most commonly measured lipid fractions—LDL cholesterol, HDL cholesterol, and triglycerides—in the development of coronary artery disease and diabetes, particularly the observed link between statin therapy and an increased risk of diabetes. More on the study, and how the results can help to identify the potential effects of lipid-modifying drugs, is available at Family Practice News : http://www.familypracticenews.com/specialty-focus/cardiology/single-article-page/rises-in-ldl-and-hdl-cholesterol-triglycerides-tied-to-lower-diabetes-risk/1c99fd4b400f60185df3f4de7d895f5f.html.

Recommended Reading

Two incretin-based drugs linked to increased bile duct disease but not pancreatitis
MDedge Family Medicine
Rises in LDL and HDL cholesterol, triglycerides tied to lower diabetes risk
MDedge Family Medicine
Is an SGLT2 inhibitor right for your patient with type 2 diabetes?
MDedge Family Medicine
Former chief of Endocrine Society: Send HbA1c packing
MDedge Family Medicine
Rethinking diabetes nutrition: No more carb mixes?
MDedge Family Medicine
FDA official: We’re monitoring DIY artificial pancreas boom
MDedge Family Medicine
Sleep doctor: Less than 7 hours can worsen diabetes
MDedge Family Medicine
Evidence doesn’t support tight glycemic control
MDedge Family Medicine
Experts: Insulin apps can pose major risks
MDedge Family Medicine
Type 2 diabetes peer-led intervention in primary care tied to improved depression symptoms
MDedge Family Medicine